PhD Scholarship in Signaling and Proteomics – CABIMER, Seville, Spain

Postdoc in Spain

PhD Scholarship in Signaling and Proteomics: A fully funded 4-year PhD position is available starting early 2026 at the Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER) in Seville, Spain. The project focuses on understanding the role of ubiquitin and SUMO modifications in genome biology through advanced proteo-genomic approaches.’

PhD Scholarship in Ubiquitin Signaling and Proteomics – CABIMER, Seville


📌 Designation

PhD Researcher


🔬 Research Area

  • Ubiquitin Signaling
  • SUMO Biology
  • Genome Biology
  • Proteomics & Genomics
  • Biochemistry & Molecular Biology

📍 Location

CABIMER (Andalusian Center for Molecular Biology and Regenerative Medicine), Seville, Spain


✅ Eligibility / Qualification

  • Master’s degree (official and recognized in the EU) in Biology or related disciplines
  • Strong motivation and interest in working at the interface of genomics and proteomics
  • Proficiency in English as a working language
  • Must hold an EU work permit
  • Young, enthusiastic scientist ready to enroll in a Doctorate Program

📝 Job Description

  • Join a dynamic Ubiquitin Signaling and Proteomics Laboratory led by Dr. Romi González Prieto
  • Work on the project PID2024-159761NB-100: Role of Ubiquitin and SUMO in Genome Biology
  • Investigate how post-translational modifications regulate genome replication, stability, expression, and organization
  • Employ mammalian cell culture models along with state-of-the-art proteo-genomic technologies
  • Benefit from CABIMER’s advanced research infrastructure in Microscopy, Genomics, and Proteomics

📧 How to Apply

  • Official call expected to open in October 2025 for a short time-frame.
  • Extra-official applications are welcome now.
  • Send the following documents to roman.gonzalez@cabimer.es:
    • Motivation Letter
    • Contact details of two references
    • Academic Record

⏳ Last Date to Apply

  • October 2025 (official call window)
  • Early submissions encouraged

LEAVE A REPLY

Please enter your comment!
Please enter your name here